search button

Remifentanil functions in the adaptive protection of cardiac function following ischemia

  • Authors:
    • Jie Hou
    • Huishan Wang
    • Xinmin Li
    • Yan Zhu

  • View Affiliations

  • Published online on: February 15, 2017     https://doi.org/10.3892/etm.2017.4124
  • Pages: 1514-1520
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate the effects of remifentanil during adaptation followinsg myocardial ischemia, and its possible clinical applications. Remifentanil was used during the simulation of adaptation following ischemia, which was performed using a Langendorff heart perfusion system. A total of 75 rats were divided into five groups, and the coronary flow, cardiac output and the cardiac enzyme content in coronary effluent prior to ischemia and post-reperfusion were recorded. Electron microscopy was used to observe myocardial ultrastructure, and the volume of aortic and coronary effluent was also measured. The recovery of cardiac output upon reperfusion was significantly higher following remifentanil treatment (91%), as compared with the ischemic control group (78%; P<0.05). The coronary flow of the experimental group following reperfusion decreased by 4 ml/min compared with the control group not exposed to ischemia, whilst the coronary flow of the ischemic control group was reduced by 20‑24 ml/min. Flameng scoring of the mitochondria demonstrated improved mitochondrial ultrastructure following remifentanil treatment (score, 1.25±0.31), as compared the ischemic control group (score, 3.14±0.17). Lactate dehydrogenase (LDH) levels in the remifentanil‑treated group were significantly lower at 10 and 30 min post-reperfusion (15.3±7.1 and 10.2±6.8 U/l, respectively), as compared with the control group (29.7±8.3 and 20.6±6.8 U/l, respectively; P<0.05). The results of the present study suggested that the application of remifentanil following ischemia protected heart function via the opioid receptors by reducing myocardial enzyme release, and attenuating ischemia-induced changes to the myocardial cell and mitochondrial structure.
View Figures
View References

Related Articles

Journal Cover

April-2017
Volume 13 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.7
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Hou J, Wang H, Li X and Zhu Y: Remifentanil functions in the adaptive protection of cardiac function following ischemia. Exp Ther Med 13: 1514-1520, 2017
APA
Hou, J., Wang, H., Li, X., & Zhu, Y. (2017). Remifentanil functions in the adaptive protection of cardiac function following ischemia. Experimental and Therapeutic Medicine, 13, 1514-1520. https://doi.org/10.3892/etm.2017.4124
MLA
Hou, J., Wang, H., Li, X., Zhu, Y."Remifentanil functions in the adaptive protection of cardiac function following ischemia". Experimental and Therapeutic Medicine 13.4 (2017): 1514-1520.
Chicago
Hou, J., Wang, H., Li, X., Zhu, Y."Remifentanil functions in the adaptive protection of cardiac function following ischemia". Experimental and Therapeutic Medicine 13, no. 4 (2017): 1514-1520. https://doi.org/10.3892/etm.2017.4124